Evidence map›Paper›PMID 22926339›Full record

Trial reportCancer prevention research (Philadelphia, Pa.)2012

A pilot study of low-cost, high-resolution microendoscopy as a tool for identifying women with cervical precancer.

Mark C Pierce, YaoYao Guan, Mary Kate Quinn, Xun Zhang, Wen-Hua Zhang, You-Lin Qiao, Philip Castle, Rebecca Richards-Kortum

Registry-linked trialOpen access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Cancer prevention research (Philadelphia, Pa.), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04472455 (Mobile High-Resolution Microendoscopy), which is not on this map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04472455 completednot on this mapstarted 2015, after this paper: background citation

Mobile High-Resolution Microendoscopy (mHRME) for the Detection of Cervical Dysplasia in El Salvador

TypeobservationalSponsorWilliam Marsh Rice UniversityRan2015 to 2019Enrolled1,827ConditionsCervical CancerArmsHRME
3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 63 citations in OpenAlex.

  1. Trial
  2. Cancer prevention research (Philadelphia, Pa.) · 2018
    Trial
  3. Diagnosing Cervical Neoplasia in Rural Brazil Using a Mobile Van Equipped withCancer prevention research (Philadelphia, Pa.) · 2018
    Trial
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Article
  9. Multi-task network for automated analysis of high-resolution endomicroscopy images to detect cervical precancer and cancer.Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society · 2022
    Article
  10. PARP1: A Potential Molecular Marker to Identify Cancer During Colposcopy Procedures.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2021
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Mark C PierceDepartment of Biomedical Engineering, Rutgers, The State University of New Jersey, Piscataway, New Jersey, USA.
YaoYao Guan
Mary Kate Quinn
Xun Zhang
Wen-Hua Zhang
You-Lin Qiao
Philip Castle
Rebecca Richards-Kortum
Albert Einstein College of Medicine · USRice University · USRutgers, The State University of New Jersey · USJohns Hopkins Medicine · USJohns Hopkins University · US

Funding

Integrated Optical Needle (ION) for Cellular and Molecular Imaging of CancerR01EB007594 · NIBIB · RICE UNIVERSITY · PI RICHARDS-KORTUM, REBECCA R. · 2008 to 2011
$1.6M
NIBIB NIH HHS R01 EB007594
6 · The paper itself

Abstract

Cervical cancer remains one of the leading causes of death among women in developing countries. Without resources to support Pap smear cytology and colposcopy, cost-effective approaches which enable single-visit "see-and-treat" protocols offer the potential to reduce morbidity and mortality due to this preventable disease. We carried out a pilot clinical study in Shanxi province, China, to evaluate a low-cost, high-resolution microendoscope (HRME) imaging system which enables evaluation of epithelial cell morphology in vivo. HRME images were obtained at discrete sites on the cervix in 174 women, in addition to visual inspection with acetic acid (VIA) and colposcopic examination. Of 69 sites appearing abnormal on colposcopy, only 12 showed high-grade disease (CIN2+) on pathology. Quantification of the nuclear-to-cytoplasm ratio by HRME enabled an ad hoc threshold to be defined, which correctly classified all 12 sites as abnormal, whilst classifying 38 of the remaining 57 pathology normal sites as normal. All patients with biopsy confirmed high-grade disease also tested positive for high-risk human papilloma virus (HPV) DNA and were classified as abnormal by HRME. Among the remaining patients who tested positive for HPV but were either normal by colposcopy or showed <CIN2 on pathology, only 6 of 32 (18.8%) were classified as abnormal by HRME. Visual examination techniques for cervical cancer screening may overestimate the prevalence of precancerous lesions, leading to unnecessary treatment, expense, and patient stress. The results of this study suggest that evaluation of suspicious lesions by HRME may assist in ruling out immediate cryotherapy, thus increasing the efficiency of current see-and-treat programs.

Indexed as

AdultAlgorithmsColposcopyCost-Benefit AnalysisEarly Detection of CancerFemaleHumansHysteroscopyMiddle AgedPapanicolaou TestPapillomavirus InfectionsPilot ProjectsPrecancerous ConditionsPredictive Value of TestsUterine Cervical DysplasiaUterine Cervical Neoplasms

Identifiers

PMID22926339
PMCPMC3494281
OpenAlexW2164484098

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.